scholarly article | Q13442814 |
P356 | DOI | 10.1007/S13277-016-4860-1 |
P698 | PubMed publication ID | 26873486 |
P2093 | author name string | Hong Jiang | |
Lei Pan | |||
Wei Han | |||
Sheng Zhao | |||
Yali Xu | |||
Jin Qian | |||
Lixin Sun | |||
Jiakai Li | |||
Xiaorong Ma | |||
Xiaobin Li | |||
Xinying Xue | |||
Zuojun Liu | |||
Xinmin Ding | |||
Mingming Meng | |||
Tuo Su | |||
P2860 | cites work | TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas | Q38352213 |
Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis | Q39931092 | ||
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma | Q40005246 | ||
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells | Q40137818 | ||
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase | Q40954925 | ||
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma | Q41815132 | ||
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults | Q42597179 | ||
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. | Q53664665 | ||
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells | Q57279527 | ||
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes | Q24338639 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma | Q24613755 | ||
Initial genome sequencing and analysis of multiple myeloma | Q24629117 | ||
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma | Q24676965 | ||
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway | Q28214369 | ||
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma | Q28250998 | ||
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma | Q28256118 | ||
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas | Q28292747 | ||
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation | Q29617419 | ||
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma | Q33432504 | ||
Cellular origin of human B-cell lymphomas. | Q33772424 | ||
The noncanonical NF-κB pathway | Q34031207 | ||
Pathogenesis of human B cell lymphomas | Q34245261 | ||
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. | Q34277639 | ||
Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma | Q34407534 | ||
Frequent inactivation of A20 in B-cell lymphomas | Q34607223 | ||
Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL). | Q34983966 | ||
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications | Q35029409 | ||
Proteases, extracellular matrix, and cancer: a workshop of the path B study section | Q35097428 | ||
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas | Q35989467 | ||
Mechanisms of B-cell lymphoma pathogenesis | Q36085626 | ||
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation | Q36362226 | ||
Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response | Q36368953 | ||
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture | Q36400143 | ||
The biology of Hodgkin's lymphoma | Q37349652 | ||
The microenvironment in mature B-cell malignancies: a target for new treatment strategies | Q37563816 | ||
BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis | Q37761495 | ||
P433 | issue | 8 | |
P304 | page(s) | 10745-10752 | |
P577 | publication date | 2016-02-12 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Bone marrow stromal cells induced activation of nuclear factor κB signaling protects non-Hodgkin's B lymphoma cells from apoptosis. | |
P478 | volume | 37 |
Q47669883 | BAFF is involved in macrophage-induced bortezomib resistance in myeloma. |
Q38889427 | Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells. |
Q64239856 | Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels |
Q41200607 | The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy. |